Loading organizations...
Loading organizations...
The EVERY Company is a technology company.
The EVERY Company develops and produces animal-free egg protein ingredients using precision fermentation. These functional powders replicate traditional egg white properties, offering a sustainable alternative for diverse food applications. A patented process programs yeast to brew specific egg proteins, ensuring consistent quality and performance for partners.
Arturo Elizondo co-founded the company, initially Clara Foods, approximately a decade ago. Educated at Harvard, Elizondo transitioned from a federal government career. He was driven by an insight to address traditional food production inefficiencies, envisioning a resilient system using biotechnology to decouple essential proteins from animal agriculture.
The company primarily serves food and beverage manufacturers, providing ingredients for products from baked goods and beverages to specialty culinary items. The EVERY Company’s mission is to future-proof the global food supply with a consistent, high-quality source of functional egg protein. They aim to transform how these crucial ingredients are produced and consumed.
The EVERY Company has raised $285.1M across 6 funding rounds.
The EVERY Company has raised $285.1M in total across 6 funding rounds.
The EVERY Company is a biotechnology firm specializing in producing animal-free egg proteins through precision fermentation technology. It serves food manufacturers and the broader food industry by providing sustainable, functional egg protein alternatives that replicate the performance, flavor, and nutritional benefits of traditional eggs without involving animals. This innovation addresses the environmental and ethical challenges of conventional egg production while enabling food companies to create products with consistent quality and supply. The company has demonstrated strong growth momentum, raising over $246 million in funding and securing partnerships with major food corporations, including distribution through Walmart and collaborations with Ingredion and AB InBev[1][2][3][5].
Founded in 2014 by David Anchel and Arturo Elizondo, both members of the New Harvest community, The EVERY Company (formerly Clara Foods) emerged from a vision to create animal proteins without livestock. The founders leveraged advances in yeast bio-fermentation to develop scalable, animal-free egg proteins. Early traction included launching the first animal-free pepsin in 2020 and gaining commercial sales across three continents. A pivotal moment was the debut of EVERY Egg, the world’s first liquid egg made without hens, showcased at Eleven Madison Park, a three-Michelin-star restaurant, signaling the company’s readiness to compete directly with traditional egg products[1][2][5][8].
The EVERY Company rides the rising trend of alternative proteins and sustainable food production, addressing urgent global challenges such as climate change, animal welfare, and food security. The timing is critical as consumer demand for plant- and fermentation-based proteins accelerates alongside technological advances in synthetic biology and fermentation. Market forces favor scalable, reliable, and functional protein ingredients that can replace animal products without compromising taste or performance. By pioneering precision fermentation for egg proteins, The EVERY Company influences the broader ecosystem by setting new standards for ingredient innovation, supply chain stability, and sustainability in the food industry[2][3][5].
Looking ahead, The EVERY Company is poised to expand manufacturing capacity and deepen its footprint across food sectors, moving from co-branded products to becoming a confidential ingredient supplier for multinational food companies. The company aims to drive profitability while scaling production to meet growing demand. Trends shaping its journey include increasing regulatory support for alternative proteins, consumer shifts toward sustainable diets, and technological improvements in fermentation efficiency. Its influence is likely to grow as it enables food brands to reformulate products with animal-free proteins at scale, potentially redefining protein sourcing in the global food system[3][5].
In summary, The EVERY Company exemplifies the convergence of biotechnology and food innovation, transforming how egg proteins are produced and consumed, with significant implications for sustainability and the future of food.
The EVERY Company has raised $285.1M in total across 6 funding rounds.
The EVERY Company's investors include McWin Capital Partners, Gabriel Ruimy, Brkfst Club, Main Sequence Ventures, Mayfield, NEO, SOSV, UpHonest Capital, Vamos Ventures, Gary Hirshberg, Hadi Partovi, Scott Banister.
The EVERY Company has raised $285.1M across 6 funding rounds. Most recently, it raised $55.0M Series D in November 2025.